Trichothecenes induce accumulation of glucosylceramide in neural cells by interfering with lactosylceramide synthase activity.
Trichothecenes are sesquiterpenoid metabolites produced by several fungal strains that impair human and animal health. Since sphingolipids were connected with fungal toxicity the aim of the present study was to test the influence of fungal metabolites on sphingolipid metabolism in neural cells. The crude extract of fungal strain Spicellum roseum induced accumulation of glucosylceramide (GlcCer), and simultaneous reduction of the formation of lactosylceramide (LacCer) and complex gangliosides in primary cultured neurons. Following a bioassay-guided fractionation of the respective fungal extract we could demonstrate that the two isolated trichothecene derivatives, 8-deoxy-trichothecin (8-dT) and trichodermol (Td-ol) were responsible for this effect. Thus, incubation of primary cultured neurons as well as of neuroblastoma B104 cells for 24 h with 30 microM of either of the two fungal metabolites resulted in uncoupling of sphingolipid biosynthesis at the level of LacCer. For the observed reduction of LacCer synthase activity by about 90% cell integrity was crucial in both cell types. In neuroblastoma cells the amount of LacCer synthase mRNA was reduced in the presence of trichothecenes, whereas in primary cultured neurons this was not the case, suggesting a post-transcriptional mechanism of action in the latter cell type. The data also show that the compounds did not interfere with the translocation of GlcCer in neuroblastoma cells. Collectively, our results demonstrate that trichodermol and 8-deoxy-trichothecin inhibit LacCer synthase activity in a cell-type-specific manner.
Kralj
Ana
A
Institute for Pharmaceutical Biology, University of Bonn, Germany.
Gurgui
Mihaela
M
König
Gabriele M
GM
van Echten-Deckert
Gerhild
G
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D001692:Biological Transport; D002478:Cells, Cultured; D005658:Fungi / Q000737:chemistry*; D005700:Galactosyltransferases / Q000187:drug effects* / Q000378:metabolism; D005732:Gangliosides / Q000378:metabolism; D005963:Glucosylceramides / Q000378:metabolism*; D006801:Humans; D007790:Lactosylceramides / Q000378:metabolism; D051379:Mice; D009447:Neuroblastoma / Q000201:enzymology; D009474:Neurons / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D012323:RNA Processing, Post-Transcriptional / Q000187:drug effects; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D014243:Trichodermin / Q000302:isolation & purification / Q000633:toxicity; D014255:Trichothecenes / Q000302:isolation & purification / Q000633:toxicity*
D015703:Antigens, CD; D005732:Gangliosides; D005963:Glucosylceramides; D007790:Lactosylceramides; D012333:RNA, Messenger; D014255:Trichothecenes; C025711:trichothecin; C009744:CDw17 antigen; D014243:Trichodermin; D005700:Galactosyltransferases; C039090:UDPgalactose-glucosylceramide galactosyltransferase